Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18081cc10bddaebf2623ddced2b7355e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16eba33202fa3711ce71002b7af1c730 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aef1fc1af474b8dd751b05b7335ac62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38641ad08cb21a510d7aebdd5b6c165b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5f8c1b7133d1a44b311b814e244019d |
publicationDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2524967-A1 |
titleOfInvention |
Methods and kits for diagnosing colorectal cancer |
abstract |
The invention pertains to a method for early detection and screening of colorectal cancer in human subjects based on RNA isolated from blood obtained from said subject. According to the invention, the abundance of at least 250 RNAs listed in tables 1 to 4 is measured. Using the invention, an accurate and noninvasive screening and diagnosis tool for colorectal cancer is provided with a sensitivity of at least 75 % and a specificity of 85 % that has high clinical utility and the potential for broad adoption. |
priorityDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |